We’re honored that the SetPoint System has been named one of @TIME’s Best Inventions of 2025 in Medical & Healthcare. 🏆 Read about it here: https://t.co/RD4wA8eVl4 Please see important safety information at https://t.co/wgUlNYJOwy #TIMEBestInventions #StartActivating #RA

Interpreting the RESET-RA 12-month outcomes: What matters for clinical decision-making https://t.co/0B92Y54fQa #RheumatoidArthritis #SetPointMedical #ACR2025 #AutoimmuneDisease #NeuroimmuneModulation #VagusNerve #RACommunity #MedTech #Inflammation #ChronicCare

SetPoint Medical to present new 12-month rheumatoid arthritis data at ACR 2025 ahead of U.S. launch https://t.co/1dA8bObrzq #SetPointMedical #RheumatoidArthritis #ACR2025 #BioelectronicMedicine #FDAApproval #RAtherapy #AutoimmuneInnovation #NeuroimmuneModulation

The SetPoint System reduces treatment burden because, once activated, it automatically delivers therapy for one minute each day for up to ten years, requiring only a few minutes of battery charging each week. #RheumatoidArthritis #BioelectronicMedicine #SetPointMedical

Kevin Tracey, president of the Feinstein Institute for Medical Research, on the future of #Bioelectronic Medicine https://t.co/eiNVSdnMaQ

🔥هيئة الغذاء والدواء @US_FDA وافقت على أول جهاز يزرع في الجسم يحفز العصب الحائر لعلاج التهاب المفاصل الروماتيزمي (الروماتيزم/روماتويد)، الجهاز بحجم الكبسولة 💊The SetPoint System 🎯٧٥%ممن تم تجربته عليهم استغنوا عن أدوية الروماتيزم بعد سنة من استخدامه https://t.co/XM1kQEJSLe 3️⃣

FDA #approves SetPoint Investigational Device Exemption - can begin #RA #pilottrial w/ proprietary #bioelectronicmedicine device https://t.co/s0issM9so5

Daily medtech news with Smarteeva: 01 Aug ☑️ @BioventusGlobal receives FDA clearance for two nerve stim devices. The TalisMann and StimTrial systems are designed for peripheral nerve stimulation. ☑️ @SetPointMedical wins FDA nod for neuroimmune arthritis therapy. The

Here at #UNMNeurosurgery we are proud of our Faculty's Medical Science achievements! Drs. Heather Spader and James Botros pictured below along with the #SetPointMedical team after the enrollment of the first patient in Stage 2 of a study for the treatment of rheumatoid arthritis.

https://t.co/YC81qrc2YZ

We’re thrilled to see the #SetPointSystem featured on @NPR. The story spotlights Lynn, who found relief after years of debilitating RA pain. Please see important safety information at https://t.co/wgUlNYJOwy https://t.co/jeBP41JeGS

🧪 La FDA de EE. UU. dio luz verde a un implante que controla la inflamación, rigidez y dolor articular de la artritis reumatoide mediante impulsos eléctricos en el nervio vago. 🩻⚡️ Conoce más de este dispositivo. 👇 https://t.co/pfopkzHddf

@SetPointMed @MarkRichardson @MGHNeuroSci https://t.co/zc6yQ5H5Oo

SetPoint Medical Submits PMA of SetPoint System to the US FDA for Treating Rheumatoid Arthritis https://t.co/n4hIOVccM5 #setpointmedical #setpointsystem #rheumatoidarthritis #medtech #pmasubmission #usfd

Added to SetPoint website: our overview of #bioelectronicmedicine on @Medtech_Insight https://t.co/PkFN0r7LjX

Neuromodulation for Inflammation: http://t.co/pLXzXsdYnN

SetPoint Medical announces Murthy Simhambhatla as new President and CEO. We welcome his extensive healthcare industry leadership as we advance our proprietary #bioelectronicmedicine platform to treat patients with debilitating #autoimmune diseases. https://t.co/2DneZkIGb4

This post is sponsored by SetPointMedical 🙌

SetPoint Medical wins FDA IDE trial nod for rheumatoid arthritis implant trial https://t.co/xPyUESPhpb #SetPoint #SetPointMedical #medtech #bioelectronic #device #meddevice #arthritis #FDA